Innospec Inc. (NASDAQ: IOSP)

Sector: Basic Materials Industry: Specialty Chemicals CIK: 0001054905
Market Cap 1.95 Bn
P/B 2.37
P/E 29.19
P/S 1.42
ROIC (Qtr) 9.06
Div Yield % 2.04
Rev 1y % (Qtr) -0.34
Total Debt (Qtr) 49.00 Mn
Debt/Equity (Qtr) 0.04

About

Innospec Inc. (IOSP) is a prominent player in the global specialty chemical industry, known for its innovative solutions and wide range of products. The company operates in various markets, including the Americas, Europe, the Middle East, Africa, and Asia-Pacific. It has a significant presence in three main segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. The Performance Chemicals segment is a crucial part of Innospec's business, offering technology-based solutions for a diverse set of industries such as personal care,...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 102.60M provides robust 2.09x coverage of total debt 49M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 270.80M provide 16.93x coverage of short-term debt 16M, demonstrating strong liquidity position and minimal refinancing risk.
  • Operating cash flow of 102.60M provides strong 14.45x coverage of stock compensation 7.10M, indicating sustainable incentive practices.
  • Strong tangible asset base of 1.34B provides 27.27x coverage of total debt 49M, indicating robust asset backing and low credit risk.
  • Strong cash position of 270.80M provides 1.52x coverage of other current liabilities 177.90M, indicating excellent liquidity.

Bear case

  • Operating cash flow of 102.60M barely covers its investment activities of (76.50M), with a coverage ratio of -1.34, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 102.60M provides thin coverage of dividend payments of (40.60M) with a -2.53 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Investment activities of (76.50M) provide weak support for R&D spending of 52.70M, which is -1.45x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Cash reserves of 270.80M provide limited coverage of acquisition spending of (2M), which is -135.40x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating cash flow of 102.60M provides minimal -7.54x coverage of tax expenses of (13.60M), suggesting potential tax planning inefficiencies or unsustainable tax positions.

Subsegments Breakdown of Revenue (2024)

Subsegments Breakdown of Revenue (2024)

Peer comparison

Companies in the Specialty Chemicals
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 LIN Linde Plc 218.63 Bn 38.41 6.61 25.93 Bn
2 SHW Sherwin Williams Co 110.34 Bn 170.54 11.54 13.58 Bn
3 ECL Ecolab Inc. 80.35 Bn 80.18 5.93 8.67 Bn
4 APD Air Products & Chemicals, Inc. 56.37 Bn 48.29 5.86 18.31 Bn
5 PPG Ppg Industries Inc 34.00 Bn 31.05 2.58 7.91 Bn
6 LYB LyondellBasell Industries N.V. 17.46 Bn 5.03 0.49 13.22 Bn
7 DD DuPont de Nemours, Inc. 16.63 Bn 3.65 0.32 8.90 Bn
8 ALB Albemarle Corp 14.44 Bn 48.94 6.36 3.63 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.16 1.52
EV to Cash from Ops. EV/CFO 20.72 12.52
EV to Debt EV to Debt 42.53 13.65
EV to EBIT EV/EBIT 14.65 21.45
EV to EBITDA EV/EBITDA 11.57 14.82
EV to Free Cash Flow [EV/FCF] EV/FCF 29.56 29.24
EV to Market Cap EV to Market Cap 1.07 3.84
EV to Revenue EV/Rev 1.52 89.11
Price to Book Value [P/B] P/B 2.37 5.48
Price to Earnings [P/E] P/E 29.19 16.02
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) -0.03 -5.31
Dividend Payout Ratio % Div Payout % (Qtr) -3,260.00 -75.74
Dividend per Basic Share Div per Share (Qtr) 1.63 1.25
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 143.99 23.50
Interest Coverage Int. cover (Qtr) 2.59 -8.92
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -19.58 -1.67
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -10.86 72.99
Dividend Growth (1y) % Div 1y % (Qtr) 10.14 -3.00
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -101.38 -31.21
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -32.01 51.49
EBIT Growth (1y) % EBIT 1y % (Qtr) -112.90 0.57
EBT Growth (1y) % EBT 1y % (Qtr) -107.83 -80.35
EPS Growth (1y) % EPS 1y % (Qtr) -100.87 -90.82
FCF Growth (1y) % FCF 1y % (Qtr) -83.36 -50.40
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -10.88 219.02
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.99 0.70
Cash Payout Ratio Cash Payout (Qtr) 0.23 0.41
Cash Ratio Cash Ratio (Qtr) 0.76 1.28
Current Ratio Curr Ratio (Qtr) 2.78 3.42
Debt to Equity Ratio Debt/Equity (Qtr) 0.04 0.92
Interest Cover Ratio Int Coverage (Qtr) 2.59 -8.92
Times Interest Earned Times Interest Earned (Qtr) 2.59 -8.92
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 1.20 -333.97
EBIT Margin % EBIT Margin % (Qtr) -1.35 -374.34
EBT Margin % EBT Margin % (Qtr) -0.83 -379.75
Gross Margin % Gross Margin % (Qtr) 28.00 29.26
Net Profit Margin % Net Margin % (Qtr) -0.10 -380.67